- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Helix BioPharma Corp. (HBP)
Helix BioPharma Corp. stock price live, this page displays TSX HBP stock exchange data. View the HBP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Helix BioPharma Corp. real time stock price chart below.
What Is the Helix BioPharma Corp. Stock Price Today?
The Helix BioPharma Corp. stock price today is 1.350.
What Is the Stock Symbol for Helix BioPharma Corp.?
The stock symbol for Helix BioPharma Corp. is ""HBP.""
What Stock Exchange Does Helix BioPharma Corp. Trade On?
Helix BioPharma Corp. is listed and trades on the Toronto stock exchange.
Is Helix BioPharma Corp. a Good Stock to Buy?
Determining whether Helix BioPharma Corp.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HBP quote. (ISIN: CA4229102088)
What Is the Helix BioPharma Corp. Stock Price Today?
The Helix BioPharma Corp. stock price today is 1.350.
What Is the Stock Symbol for Helix BioPharma Corp.?
The stock symbol for Helix BioPharma Corp. is ""HBP.""
What Stock Exchange Does Helix BioPharma Corp. Trade On?
Helix BioPharma Corp. is listed and trades on the Toronto stock exchange.
Is Helix BioPharma Corp. a Good Stock to Buy?
Determining whether Helix BioPharma Corp.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HBP quote. (ISIN: CA4229102088)
Toronto
Currency in CAD
1.350
-0.030(-2.17%)
Real-time Data·
Fair Value
An estimate of a Helix BioPharma Corp.'s true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.340
1.380
52 wk Range
0.500
1.400
HBP Scorecard
Full Analysis
Significant return over the last week
HBP is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Helix BioPharma Corp.'s true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.3401.380
52 wk Range
0.5001.400
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
HBP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Helix BioPharma Corp.'s true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Helix BioPharma Corp. Company Profile
Helix BioPharma Corp. operates as an immune-oncology company in Canada. Its product pipeline comprises L-DOS47, a clinical-stage antibody-enzyme conjugate (AEC) that neutralizes the microenvironment of solid tumors; LDOS001, which is in phase I clinical trial to treat non-small cell lung cancer; LDOS002, which is in phase I/II clinical trial for the treatment of non-small cell lung cancer; LDOS003, which is in phase II clinical trial to treat non-small cell lung cancer; LDOS006, which is in phase Ib/II for the treatment of pancreatic cancer. It develops V-DOS47, an antibody-DOS47 conjugate that targets the vascular endothelial growth factor 2 receptor. It has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. Helix BioPharma Corp. was incorporated in 2008 and is headquartered in Vancouver, Canada.
Compare HBP to Peers and Sector
Metrics to compare | HBP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHBPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −10.7x | −4.5x | −0.6x | |
PEG Ratio | 0.41 | 0.04 | 0.00 | |
Price/Book | −73.6x | 0.5x | 2.6x | |
Price / LTM Sales | - | 2.3x | 3.3x | |
Upside (Analyst Target) | - | 143.2% | 40.1% | |
Fair Value Upside | Unlock | −2.0% | 5.3% | Unlock |
Earnings
Latest Release
Jun 16, 2025
EPS / Forecast
-0.03 / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Helix BioPharma Corp. Trade On?
Helix BioPharma Corp. is listed and trades on the Toronto Stock Exchange stock exchange.
What Is the Stock Symbol for Helix BioPharma Corp.?
The stock symbol for Helix BioPharma Corp. is "HBP."
What Is the Helix BioPharma Corp. Market Cap?
As of today, Helix BioPharma Corp. market cap is 100.11M.
What Is Helix BioPharma Corp.'s Earnings Per Share (TTM)?
The Helix BioPharma Corp. EPS (TTM) is -0.19.
From a Technical Analysis Perspective, Is HBP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Helix BioPharma Corp. Stock Split?
Helix BioPharma Corp. has split 1 times.
How Many Employees Does Helix BioPharma Corp. Have?
Helix BioPharma Corp. has 7 employees.
What is the current trading status of Helix BioPharma Corp. (HBP)?
As of 20 Aug 2025, Helix BioPharma Corp. (HBP) is trading at a price of 1.35, with a previous close of 1.38. The stock has fluctuated within a day range of 1.34 to 1.38, while its 52-week range spans from 0.50 to 1.40.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.